CLLS

Cellectis S.A.

6 catalysts on file

CLLS

Cellectis S.A.

Phase 2 AI-extracted

lasme-cel

relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

T-minus 87 days ~ Oct 1, 2026

SEC 6-K verified 10h ago

Countdown card →

CLLS

Cellectis S.A.

Phase 1 AI-extracted

eti-cel

relapsed or refractory non-Hodgkin lymphoma (r/r NHL)

T-minus 87 days ~ Oct 1, 2026

SEC 6-K verified 10h ago

Countdown card →

CLLS

Cellectis S.A.

AdCom AI-extracted

cema-cel

first-line consolidation for large B-cell lymphoma (LBCL)

T-minus 359 days ~ Jun 30, 2027

SEC 6-K verified 10h ago

Countdown card →

CLLS

Cellectis S.A.

Approval AI-extracted

lasme-cel

relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

T-minus 544 days ~ Jan 1, 2028

SEC 6-K verified 10h ago

Countdown card →

CLLS

Cellectis S.A.

Phase 2 AI-extracted

cema-cel

large B-cell lymphoma (LBCL)

T-minus 725 days ~ Jun 30, 2028

SEC 6-K verified 10h ago

Countdown card →

CLLS

Cellectis S.A.

Approval AI-extracted

cema-cel

first-line consolidation for large B-cell lymphoma (LBCL)

Date TBD Date TBD

SEC 6-K verified 10h ago

Countdown card →